PainReform Ltd
PRFX1.310USD
-0.010-0.76%
시장 운영 시간 （ET）시세는 15분 지연됩니다
1.93M시가총액
손실P/E TTM
자세한 내용은 PainReform Ltd 회사
PAINREFORM LTD is a Israel-based pharmaceutical Company. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.
회사 정보
종목 코드 PRFX
회사 이름PainReform Ltd
상장일Sep 01, 2020
CEOMr. Ilan Hadar
직원 수2
유형Ordinary Share
회계 연도 종료Sep 01
주소65 Yigal Alon St.
도시TEL AVIV-YAFO
증권 거래소NASDAQ Capital Market Consolidated
국가Israel
우편 번호6744316
전화97237177051
웹사이트https://painreform.com/
종목 코드 PRFX
상장일Sep 01, 2020
CEOMr. Ilan Hadar
회사 임원
이름
이름/직위
직위
주식 보유
변동
DR. Sigal Aviel
DR. Sigal Aviel
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Eli Hazum
Dr. Eli Hazum
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Mrs. Rita Keynan
Mrs. Rita Keynan
Vice President - Pharmaceutical Operations
Vice President - Pharmaceutical Operations
--
--
Dr. Ellen S. Baron
Dr. Ellen S. Baron
Independent Director
Independent Director
--
--
Mr. Efi Cohen-Arazi
Mr. Efi Cohen-Arazi
Independent Director
Independent Director
--
--
Mr. Augustine J. (Gus) Lawlor
Mr. Augustine J. (Gus) Lawlor
Independent Director
Independent Director
--
--
Dr. Ehud Geller, Ph.D.
Dr. Ehud Geller, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Mr. Ilan Hadar
Mr. Ilan Hadar
Chief Executive Officer, Chief Financial Officer
Chief Executive Officer, Chief Financial Officer
--
--
이름
이름/직위
직위
주식 보유
변동
DR. Sigal Aviel
DR. Sigal Aviel
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Eli Hazum
Dr. Eli Hazum
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Mrs. Rita Keynan
Mrs. Rita Keynan
Vice President - Pharmaceutical Operations
Vice President - Pharmaceutical Operations
--
--
Dr. Ellen S. Baron
Dr. Ellen S. Baron
Independent Director
Independent Director
--
--
Mr. Efi Cohen-Arazi
Mr. Efi Cohen-Arazi
Independent Director
Independent Director
--
--
Mr. Augustine J. (Gus) Lawlor
Mr. Augustine J. (Gus) Lawlor
Independent Director
Independent Director
--
--
수익 분석
데이터 없음
데이터 없음
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Tue, Jul 29
마지막 업데이트: Tue, Jul 29
주주
주주 유형
주주
주주
비율
Bladeranger Ltd
8.88%
Vanguard Personalized Indexing Management, LLC
0.68%
Medica Venture Partners
0.68%
L.I.A. Pure Capital Ltd
0.52%
XT Holdings Ltd
0.22%
Other
89.02%
주주
주주
비율
Bladeranger Ltd
8.88%
Vanguard Personalized Indexing Management, LLC
0.68%
Medica Venture Partners
0.68%
L.I.A. Pure Capital Ltd
0.52%
XT Holdings Ltd
0.22%
Other
89.02%
주주 유형
주주
비율
Corporation
9.62%
Investment Advisor
0.69%
Private Equity
0.68%
Hedge Fund
0.02%
Other
88.98%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
22
221.75K
11.02%
-42.46K
2025Q1
21
208.02K
26.50%
+122.57K
2024Q4
19
72.04K
4.22%
+19.22K
2024Q3
16
43.23K
4.31%
+4.77K
2024Q2
16
35.44K
14.31%
+7.32K
2024Q1
15
25.67K
11.49%
-2.27K
2023Q4
17
26.00K
30.19%
+5.33K
2023Q3
18
17.50K
39.02%
-5.90K
2023Q2
18
20.07K
100.28%
-3.32K
2023Q1
19
20.05K
44.89%
-6.93K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Bladeranger Ltd
178.77K
8.88%
--
--
Apr 01, 2025
Medica Venture Partners
13.72K
0.68%
+2.00
+0.01%
Apr 01, 2025
L.I.A. Pure Capital Ltd
10.42K
0.52%
+10.42K
--
Aug 28, 2024
XT Holdings Ltd
4.44K
0.22%
+887.00
+24.96%
Dec 31, 2023
Tower Research Capital LLC
472.00
0.02%
+472.00
--
Mar 31, 2025
Osaic Holdings, Inc.
193.00
0.01%
--
--
Mar 31, 2025
SBI Securities Co., Ltd.
6.00
0%
--
--
Mar 31, 2025
Virtu Americas LLC
--
0%
-836.00
-100.00%
Sep 30, 2024
Susquehanna International Group, LLP
--
0%
-561.00
-100.00%
Mar 31, 2024
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
Nov 19, 2024
Merger
4<1
Nov 19, 2024
Merger
4<1
Nov 19, 2024
Merger
4<1
Nov 19, 2024
Merger
4<1
Sep 05, 2024
Merger
6<1
Sep 05, 2024
Merger
6<1
날짜
유형
비율
Nov 19, 2024
Merger
4<1
Nov 19, 2024
Merger
4<1
Nov 19, 2024
Merger
4<1
Nov 19, 2024
Merger
4<1
Sep 05, 2024
Merger
6<1
Sep 05, 2024
Merger
6<1
Sep 05, 2024
Merger
6<1
Sep 05, 2024
Merger
6<1
Jun 30, 2023
Merger
10<1
Jun 30, 2023
Merger
10<1
더 보기
